Large Volume Parenteral (LVP) Market Report by Type (Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP), Volume (100 ML - 250 ML, 250 ML - 500 ML, 500 ML - 1000 ML, 1000 ML - 2000 ML, 2000 ML and More), Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), End Users (Hospitals, Clinics, and Others), and Region 2025-2033

Large Volume Parenteral (LVP) Market Report by Type (Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP), Volume (100 ML - 250 ML, 250 ML - 500 ML, 500 ML - 1000 ML, 1000 ML - 2000 ML, 2000 ML and More), Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), End Users (Hospitals, Clinics, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A5711

Market Overview:

The global large volume parenteral (LVP) market size reached USD 10.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.0 Billion by 2033, exhibiting a growth rate (CAGR) of 5.34% during 2025-2033.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
USD 10.4 Billion
Market Forecast in 2033
USD 17.0 Billion
Market Growth Rate 2025-2033 5.34%


A large volume parenteral (LVP) is a single-dose injection packaged in a glass bottle or a flexible container of more than 100ml capacity after sterilization via heat. It is injected through the skin or other external boundary tissue to directly administrate the active drug substances into the blood vessels, organs, tissues, or lesions. It generally consists of an active ingredient, water-miscible or non-aqueous vehicle, and added substances like buffers, antioxidants, preservatives, surfactants, antimicrobial agents, and tonicity adjusters. Some of the commonly available LVPs around the world are peritoneal dialysis, irrigating solutions, blood derivatives, drug premixes, and contrast agents.

Large Volume Parenteral (LVP) Market Trends:

The rising prevalence of malnutrition, growing natality rate, and increasing premature births worldwide are among the key factors catalyzing the demand for LVPs to administer a large amount of nutrients in patients who are unable to take food orally. Apart from this, they are widely used in administering essential nutrients to patients undergoing treatment for esophageal obstruction, gastrointestinal (GI) diseases, cancer, and ulcer. In addition, LVPs find extensive application in heart surgery to prevent ischemic injury to the myocardium during reperfusion and the blood flow supply restriction. This, in confluence with the escalating demand for safe, fast, and effective methods of drug administration among patients undergoing surgical interventions, is contributing to the market growth. Besides this, the growing consumption of fast food across the globe has resulted in rising instances of non-communicable diseases, such as hypertension, diabetes, obesity, and other metabolic disorders. This, in turn, is positively influencing the adoption of LVPs that are a mixture of dextrose, amino acids, lipids, added electrolytes, trace metals, and vitamins.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global large volume parenteral (LVP) market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on type, volume, application and end users.

Breakup by Type:

  • Soft Bag LVP
  • Plastic Bottle LVP
  • Glass Bottle LVP
     

Breakup by Volume:

  • 100 ML - 250 ML
  • 250 ML - 500 ML
  • 500 ML - 1000 ML
  • 1000 ML - 2000 ML
  • 2000 ML and More
     

Breakup by Application:

  • Therapeutic Injections
  • Fluid Balance Injections
  • Nutritious Injections
     

Breakup by End Users:

  • Hospitals
  • Clinics
  • Others
     

Breakup by Region:

Large Volume Parenteral (LVP) Market By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Albert David Ltd., B. Braun Melsungen AG, Baxter International Inc., BML Parenteral Drugs, Fresenius Kabi AG, Grifols S.A, Otsuka Pharmaceutical Co. Ltd, Pharmaceutical Solutions Industry Ltd., Sichuan Kelun Pharmaceutical Co. Ltd. and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Type, Volume, Application, End Users, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Albert David Ltd., B. Braun Melsungen AG, Baxter International Inc., BML Parenteral Drugs, Fresenius Kabi AG, Grifols S.A, Otsuka Pharmaceutical Co. Ltd, Pharmaceutical Solutions Industry Ltd., Sichuan Kelun Pharmaceutical Co. Ltd. and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global large volume parenteral (LVP) market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global large volume parenteral (LVP) market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the volume?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end users?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global large volume parenteral (LVP) market and who are the key players?
  • What is the degree of competition in the industry?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Large Volume Parenteral (LVP) Market Report by Type (Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP), Volume (100 ML - 250 ML, 250 ML - 500 ML, 500 ML - 1000 ML, 1000 ML - 2000 ML, 2000 ML and More), Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), End Users (Hospitals, Clinics, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials